Lantern Pharma Inc. (NASDAQ:LTRN) Q1 2025 Earnings Call Transcript May 15, 2025
Lantern Pharma Inc. beats earnings expectations. Reported EPS is $-0.42, expectations were $-0.49.
Operator: Good morning, and welcome to our First Quarter 2025 Earnings Call. As a reminder, this call is being recorded, and all attendees are in a listen-only mode. We will open the call for questions-and-answers after our management’s presentation. A webcast replay of today’s conference call will be available on...
